Pharma Veterans

WOMEN IN THE WORKPLACE REPORT 2025 – Part 1 – Asrar Qureshi’s Blog Post #1198 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1198 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Anna Tarazevich Preamble This 2-part blog post is based on Women in the Workplace report 2025, which is prepared by McKinsey & Co. and LeanIn.org. This report is in the 11th year of publication. Link to full report here. https://www.mckinsey.com/~/media/mckinsey/business%20functions/people%20and%20organizational%20performance/our%20insights/women%20in%20the%20workplace%202025/women%20in%20the%20workplace%202025_final.pdf?shouldIndex=false  Part I: Corporate Gender Equality at a Crossroads in 2025 Introduction: A Decade of Progress Meets New Challenges In 2025, Women in the Workplace, the largest annual study of women’s represe...

WHO Report 2025 – Universal Health Coverage – Part 2 – Asrar Qureshi’s Blog Post #1197 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1197 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: CDC Library Preamble This 2-part blog post is based on WHO report on Universal Health Coverage (UHC) 2025. To access full report, use this link. https://www.who.int/publications/i/item/9789240117815  Part II – “What Must Happen Now: Translating UHC Commitments into Resilient, Equitable Health Systems” The findings of the 2025 UHC monitoring report sound a clear alarm. For advocates, policymakers, global health bodies, and national governments; urgent action is required. But the challenge is not just technical or financial: it demands vision, strategy, and sustained political commitment. Here’s a roadmap, informed by the r...

WHO Report 2025 – Universal Health Coverage – Part 1 – Asrar Qureshi’s Blog Post #1196 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1196 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Jermain Ulinwa Credit: Anna Shvets Preamble This 2-part blog post is based on WHO report on Universal Health Coverage (UHC) 2025. To access full report, use this link. https://www.who.int/publications/i/item/9789240117815  Part I — “Where We Stand in 2025: Global Progress and Gaps toward Universal Health Coverage” The principle of universal health coverage (UHC), that everyone, everywhere should have access to essential health services without financial hardship, remains one of the most ambitious and morally compelling goals in global health. The 2025 global monitoring report by WHO and the World Bank offers a fresh vanta...

Responsible Leadership – Asrar Qureshi’s Blog Post 1195 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1195 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Matheus Amaral Preamble This blog post is mainly based on an INSEAD article written by Graham Ward of INSEAD, and Anindo Bhattacharjee and Raul V. Rodriguez of Woxsen University. Link here. https://knowledge.insead.edu/career/three-responsible-leadership   Why “Responsible Leadership” Matters More Than Ever In a world defined by volatility, political upheaval, fast-changing technologies like AI, economic uncertainty, the stakes for leadership have never been higher. The article from INSEAD argues that leaders must go beyond traditional metrics of performance and profit. The challenges today call for a leadership style grounded in ethics, awareness,...

Violence Against Women – Prevalence Estimates 2023 – Part 2 – Asrar Qureshi’s Blog Post #1194 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1194 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Alex Green Credit: Mikhail Nilov Preamble This 2-part blog post is based on WHO report titled ‘Violence against Women – Prevalence Estimates 2023. The report was released in November 2025. You may see the full report following this link. https://www.who.int/health-topics/violence-against-womentab=tab_1  PART 2 – Violence Against Women: Implications, Gaps, and the Road Ahead Violence against women (VAW) is not only a tragedy for individuals; it is a deep fault line running through societies, institutions, cultures, and the global development agenda. The 2023 WHO prevalence estimates reinforce this unsettling truth: ...

Violence Against Women – Prevalence Estimates 2023 – Part 1 – Asrar Qureshi’s Blog Post #1193 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1193 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Katrina Bolovstova Credit: Gustavo Fring Credit: MART Production Credit: Alina Mayveycheva Credit: Ron Lach Preamble This 2-part blog post is based on WHO report titled ‘Violence against Women – Prevalence Estimates 2023. The report was released in November 2025. You may see the full report following this link. https://www.who.int/health-topics/violence-against-women#tab=tab_1  Part 1 – The Global Landscape of Violence Against Women: Understanding the 2023 WHO Prevalence Estimates Violence against women remains one of the most persistent, pervasive, and devastating human rights violations around the world. The 2025...